<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    111, Inc.

    verified_userVerify Profile
    Companies » Consumer Services » Food & Drug Retailers » Drug Retailers

    About 111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. By applying advanced Internet and information technology, 111,Inc. is devoted to online medical services and online pharmacy through optimized supply chain and cloud services, to increase the efficiency and transparency of drug retail and distribution. 111,Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $2,300,000,000
    • SIC CODE
      5912
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gang Yu and Junling Liu
    • FOUNDED
      2010
    • EMPLOYEES
      1001-5000
    • SECTOR
      Food & Drug Retailers
    • SUBSECTOR
      Drug Retailers

    Company Tags

    No articles found.

    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...

    NeuBase Therapeutics, Inc. is developing its mo...

    Filing Type:    PU
    RadNet, Inc.

    RadNet, Inc.

    RadNet is the national leader in outpatient imaging. Backed by 30 years of experie...

    RadNet is the national leader in outpatient ima...

    Filing Type:    PU
    Fred's, Inc.

    Fred's, Inc.

    Tracing our history back to an original store in Coldwater, Mississippi in 1947, F...

    Tracing our history back to an original store i...

    Filing Type:    PU
    NowRx, Inc.

    NowRx, Inc.

    NowRx provides a trusted, reliable way to have your prescriptions delivered, from ...

    NowRx provides a trusted, reliable way to have ...

    Amount Raised:    $2,233,127.00
    Fundraising Status:    EC
    Filing Type:    RACF
    China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    Incorporated in 2006 with headquarters in Hangzhou, China, China Jo-Jo Drugstores,...

    Incorporated in 2006 with headquarters in Hangz...

    Filing Type:    PU
    HandStack P.B.C.

    HandStack P.B.C.

    Handstack has developed Bitesize, an application that allows businesses to interac...

    Handstack has developed Bitesize, an applicatio...

    Fundraising Status:    SD
    Filing Type:    CF
    Narrative Company

    Narrative Company

    We are building a publishing platform with a built in revenue model. Content is cr...

    We are building a publishing platform with a bu...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    Bublish Inc.

    Bublish Inc.

    Bubllish is a book creation & marketing platform where authors can reach new reade...

    Bubllish is a book creation & marketing platfor...

    Amount Raised:    $300,000
    Fundraising Status:    SD
    Filing Type:    CF
    Viveve Medical, Inc.

    Viveve Medical, Inc.

    Viveve, Inc., the wholly owned subsidiary of Viveve Medical, Inc., is a women's in...

    Viveve, Inc., the wholly owned subsidiary of Vi...

    Filing Type:    PU
    SI-BONE, Inc.

    SI-BONE, Inc.

    SI-BONE is a medical device company that has pioneered a proprietary minimally inv...

    SI-BONE is a medical device company that has pi...

    Filing Type:    PU
    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc. is a leading global surgical implant company providing...

    RTI Surgical Holdings, Inc. is a leading global...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.